Regulation of Gene Expression by 8-Prenylnaringenin in Uterus and Liver of Wistar rats

Abstract

The potential estrogenic activity of 8-prenylnaringenin has been investigated using several in vitro test systems. 8-Prenylnaringenin is a natural secondary product of the female blossoms of hops. The aim of the present study was to characterize 8-prenylnaringenin for its estrogenic effects in vivo. A three day uterotrophic assay was carried out on ovariectomized young female rats. A single dose of 8-prenylnaringenin (10 mg/day/kg body mass) was administered subcutaneously. 17β-Estradiol (0.03 mg/day/kg body mass; subcutaneous administration) was used as a positive control. Uterine wet weight, endometrial and vaginal epithelial height were determined by histological methods. Gene expression in uterus and in liver was assessed using realtime RT-PCR. Both estradiol and 8-prenylnaringenin significantly stimulated uterine wet weight accompanied by a proliferative response. The three day treatment resulted in a statistically significant increase of the uterine epithelial height as well as of the vaginal epithelial height, the latter being the more sensitive parameter. In the uterus of ovariectomized animals estrogen receptor-α and clusterin gene expression were down regulated following treatment with estradiol, whereas expression of complement C3 was up-regulated. In response to treatment with 8-prenylnaringenin the same gene expression pattern was detectable, but less pronounced. The levels of estrogen receptor-α mRNA in rat liver were very low and therefore could not be quantitatively assessed. Like in the uterine tissue, estradiol down regulated clusterin expression. The response to 8-prenylnaringenin was weaker but still significant. Conversely, 8-prenylnaringenin was found to be more potent than estradiol in inducing expression of IGFBP-1. In summary, the multiparametric assessment of the estrogenic activity of 8-prenylnaringenin provides overwhelming evidence that 8-prenylnaringenin has largely to be regarded as a pure estrogen agonist and is therefore a questionable candidate molecule for hormone replacement therapy.

Key words

8-Prenylnaringenin - estrogenic activity - hops - Humulus lupulus

References

• 1 Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection.  Environ. Health Perspect.. 1995;  103 (Suppl. 7) 103-12
• 2 Lamartiniere C A, Murrill W B, Manzolillo P A, Zhang J X, Barnes S, Zhang X, et al. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats.  Proc. Soc. Biol. Med.. 1998;  217 358-64
• 3 Wang J, Eltoum I, Lamartiniere C. Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats.  Cancer Lett.. 2002;  186 11-19
• 4 Newbold R R, Banks E P, Bullock B, Jefferson W N. Uterine adenocarcinoma in mice treated neonatally with genistein.  Cancer Res.. 2001;  61 4325-8
• 5 Kitaoka M, Kadokawa H, Sugano M, Ichikawa K, Taki M, Takaishi S, Iijima Y, Tsutsumi S, Boriboon M, Akiyama T. Prenylflavonoids: a new class of non-steroidal phytoestrogen (part 1). Isolation of 8-isopentenylnaringenin and an initial study on its structure activity relationship.  Planta Medica. 1998;  64 511-5
• 6 Milligan S R, Kalita J C, Heyerick A, Rong H, De Cooman L, De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer.  J. Clin Endocrinol. Metab.. 1999;  83 2249-52
• 7 Coldham N G, Sauer M J. Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement.  Food Chem. Toxicol.. 2001;  39 1121-4
• 8 Miyamoto M, Matsushita Y, Kiyokawa A, Hukuda C, Iijima Y, Sugano M, Akiyama T. Prenylflavonoids: A new class of non-steroidal phytoestrogen (part 2). Estrogenic effects of 8-isopentenylnaringenin on bone metabolism.  Planta Medica. 1998;  64 516-9
• 9 Milligan S R, Kalita J C, Pocock V, Van der Kauter V, Stevens J F, Deinzer M L, Rong H, De Keukeleire D. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids.  J. Clin. Endocrinol. Metab.. 2000;  85 4912-15
• 10 Zierau O, Gester S, Schwab P, Metz P, Vollmer G. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin.  Planta Medica. 2002;  68 449-51
• 11 Milligan S, Kalita J, Pocock V, Heyerinck A, De Cooman L, Rong H, De Keukeleire D. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin.  Reproduction. 2002;  123 235-42
• 12 Pettersson K, Gustafsson J A. Role of estrogen receptor beta in estrogen action.  Annu. Rev. Physiol.. 2001;  63 165-92
• 13 Strunck E, Stemmann N, Hopert A C, Wünsche W, Frank K, Vollmer G. Relative binding affinity does not predict biological response to xenoesterogens in rat endometrial adenocarcinoma cells.  J. Steroid Biochem. Mol. Biol.. 2000;  74 73-81
• 14 Gester S, Metz P, Zierau O, Vollmer G. An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl)naringenin by europium(III)-catalyzed Claisen rearrangement.  Tetrahedron. 2001;  57 1015-1018
• 15 Diel P, Schmidt S, Vollmer G. In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens.  J. Chromatogr. B. 2002;  777 191-202
• 16 Winer J, Jung C K, Shackel I, Williams P M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.  Anal. Biochem. 1999;  270 41-9
• 17 Molnar P, Murphy L J. Effects of oestrogen on rat uterine expression of insulin-like growth factor-binding proteins.  J. Mol. Endocrinol.. 1994;  13 59-67
• 18 Diel P, Walter A, Fritzemeier K H, Hegele-Hartung C, Knauthe R. Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus.  J. Steroid Biochem. Mol. Biol.. 1995;  55 363-73
• 19 Suh D S, Ooi G T, Rechler M M. Identification of cis-elements mediating the stimulation of rat insulin-like growth factor-binding protein-1 promoter activity by dexamethasone, cyclic adenosine 3′,5′-monophosphate, and phorbol esters, and inhibition by insulin.  Mol. Endocrinol.. 1994;  8 794-805
• 20 Miranda C L, Stevens J F, Helmrich A, Henderson M C, Rodriguez R J, Yang Y H, et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines.  Food Chem. Toxicol.. 1999;  37 271-285
• 21 Stevens J F, Taylor A W, Clawson J E, Deinzer M L. Fate of xanthumol and related prenylflavonoids from hops to beer.  J. Agric. Food Chem.. 1999;  47 2421-8